This inventor holds 2 USPTO granted patents. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: **Inventor Spotlight: Ilkyun Im**
Introduction
Ilkyun Im is an innovative inventor based in Daejeon, South Korea, recognized for his contributions to the field of regenerative medicine. With a focus on developing methods that enhance drug metabolic capabilities, Ilkyun has dedicated his research to constructing advanced liver organoids derived from human pluripotent stem cells.
Latest Patents
Ilkyun Im holds a patent for a groundbreaking method titled "Method for constructing human pluripotent stem cell-derived liver organoid having enhanced drug metabolic potential." This invention details a method for constructing liver organoids that closely mimic the human liver's structure and function. The organoids are derived from human induced pluripotent stem cells, allowing for the easy supply of patient-specific liver organoids. These organoids consist of various cell types, including hepatocytes and cholangiocytes, and are characterized by their excellent expression of drug metabolism enzymes. They serve as valuable models for studying liver disease pathogenesis and evaluating drug stability.
Career Highlights
Ilkyun is associated with the Korea Research Institute of Chemical Technology, where he collaborates with leading researchers to push the boundaries of chemical technology and regenerative medicine. His work is not only innovative but also essential for advancing personalized medicine through tailored liver organoids.
Collaborations
In his current role, Ilkyun works alongside talented colleagues, including Han-Jin Park and Hyemin Kim. Together, they contribute to ongoing research and development efforts aimed at enhancing the applicability of liver organoids in medical research and drug discovery.
Conclusion
Ilkyun Im is a notable figure in the realm of regenerative medicine, with his pioneering patent marking a significant advancement in the development of liver organoids. His dedication to improving patient-specific therapies and understanding liver diseases positions him as a key contributor within his field. By facilitating the creation of functional liver models, Ilkyun’s research holds the potential for vast impacts on personalized medicine and pharmaceutical development.